Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

CRBP Insider Trading (Corbus Pharmaceuticals)

Insider Ownership Percentage: 8.20%
Insider Buying (Last 12 Months): $10,260.80
Insider Selling (Last 12 Months): $276,917.36

Corbus Pharmaceuticals Insider Trading History Chart

Corbus Pharmaceuticals Share Price & Price History

$1.84
▼ -0.05 (-2.65%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

Corbus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2020Sean F MoranCFOSell87,500$1.75$153,125.00403,220  
12/18/2020Sean F MoranCFOSell53,610$1.40$75,054.00403,220  
12/16/2020Sean F MoranCFOSell36,923$1.32$48,738.36386,533  
11/11/2020Yuval CohenCEOBuy4,240$1.21$5,130.4075,330  
11/11/2020Yuval CohenCEOBuy4,240$1.21$5,130.4075,330  
3/17/2020Barbara WhiteInsiderBuy15,606$3.82$59,614.92
3/17/2020Robert Paul DiscordiaCOOBuy2,840$3.82$10,848.80
11/12/2019Yuval CohenCEOBuy1,430$4.26$6,091.8066,790  
11/11/2019Craig Stuart MillianInsiderBuy1,000$4.38$4,380.0010,000  
11/11/2019Robert Paul DiscordiaCOOBuy2,500$4.62$11,550.0032,650  
8/15/2019Craig Stuart MillianInsiderBuy1,500$5.48$8,220.009,000  
8/12/2019Craig Stuart MillianInsiderBuy1,500$6.00$9,000.007,500  
8/12/2019Robert Paul DiscordiaCOOBuy15,000$5.86$87,900.0030,150  
8/12/2019Yuval CohenCEOBuy1,175$6.06$7,120.5065,360  
5/17/2019Barbara WhiteInsiderBuy1,389$7.20$10,000.80185,548  
5/14/2019Craig Stuart MillianInsiderBuy1,000$7.23$7,230.006,000  
5/14/2019Sean F MoranCFOBuy100$7.12$712.00349,610  
5/13/2019Yuval CohenCEOBuy995$6.99$6,955.0564,185  
3/15/2019John Kenneth JenkinsDirectorBuy1,000$6.98$6,980.001,000  
3/14/2019Barbara WhiteInsiderBuy4,638$6.47$30,007.86184,159  
3/14/2019Sean F MoranCFOBuy1,500$6.67$10,005.00349,510  
3/14/2019Yuval CohenCEOBuy1,530$6.49$9,929.7063,190  
5/15/2018Barbara WhiteInsiderBuy2,586$5.87$15,179.82179,521  
5/15/2018Sean F MoranCFOBuy4,000$5.77$23,080.00348,010  
5/15/2018Yuval CohenCEOBuy1,725$5.85$10,091.2561,660  
5/14/2018David P HochmanDirectorBuy5,000$5.48$27,400.00459,500  
See Full Table

SEC Filings (Institutional Ownership Changes) for Corbus Pharmaceuticals (NASDAQ:CRBP)

67.13% of Corbus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corbus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/24/2021Virtu Financial LLC153,908$0.19M0.0%N/A0.183%
2/23/2021Principal Financial Group Inc.33,163$41K0.0%+31.4%0.039%
2/19/2021JPMorgan Chase & Co.259,070$0.32M0.0%+833.9%0.308%
2/16/2021Squarepoint Ops LLC290,532$0.36M0.0%+314.9%0.346%
2/16/2021Jefferies Group LLC20,000$25K0.0%N/A0.024%
2/16/2021ETF Managers Group LLC8,103,641$10.13M0.2%+122.0%9.643%
2/16/2021Charles Schwab Investment Management Inc.447,025$0.56M0.0%-7.0%0.532%
2/12/2021Penserra Capital Management LLC104,408$0.13M0.0%+10.4%0.124%
2/12/2021LPL Financial LLC35,825$45K0.0%+163.9%0.043%
2/12/2021The Manufacturers Life Insurance Company 38,411$48K0.0%+28.3%0.046%
2/12/2021Ikarian Capital LLC139,100$0.17M0.0%-36.8%0.166%
2/12/2021Vontobel Holding Ltd.20,539$26K0.0%N/A0.024%
2/11/2021Northern Trust Corp827,845$1.04M0.0%-0.9%0.985%
2/11/2021Citigroup Inc.31,817$40K0.0%-51.5%0.038%
2/10/2021Rhumbline Advisers102,904$0.13M0.0%+15.7%0.122%
2/10/2021Renaissance Technologies LLC962,100$1.20M0.0%+2.7%1.145%
2/10/2021Reynders McVeigh Capital Management LLC20,000$25K0.0%N/A0.024%
2/10/2021D.A. Davidson & CO.21,717$27K0.0%-51.7%0.026%
2/9/2021Wells Fargo & Company MN98,195$0.12M0.0%-49.4%0.117%
2/9/2021Bank of New York Mellon Corp226,423$0.28M0.0%-17.0%0.269%
2/8/2021Alliancebernstein L.P.43,200$54K0.0%-51.1%0.051%
2/5/2021BlackRock Inc.5,220,525$6.53M0.0%-11.6%6.212%
2/5/2021SG Americas Securities LLC106,353$0.13M0.0%-91.3%0.127%
2/4/2021Cambridge Investment Research Advisors Inc.99,049$0.12M0.0%-16.3%0.118%
1/30/2021Davy Global Fund Management Ltd56,932$71K0.0%+128.7%0.068%
1/26/2021Pinnacle Associates Ltd.942,079$1.18M0.0%-19.0%1.121%
1/25/2021AdvisorShares Investments LLC271,873$0.34M0.1%-2.8%0.324%
1/22/2021Aries Wealth Management23,400$33K0.0%-29.9%0.028%
1/20/2021Kestra Advisory Services LLC27,740$36K0.0%-19.3%0.033%
11/30/2020Platform Technology Partners60,000$0.11M0.1%+200.0%0.071%
11/17/2020California State Teachers Retirement System113,023$0.20M0.0%+12.9%0.134%
11/16/2020Squarepoint Ops LLC70,026$0.13M0.0%-51.8%0.083%
11/13/2020Morgan Stanley734,526$1.32M0.0%-45.4%0.874%
11/13/2020Charles Schwab Investment Management Inc.480,716$0.87M0.0%+191.7%0.588%
11/13/2020Great West Life Assurance Co. Can114,468$1.43M0.0%+2,462.0%0.140%
11/13/2020Cambria Investment Management L.P.43,890$79K0.0%+23.5%0.054%
11/12/2020Kestra Advisory Services LLC34,370$62K0.0%N/A0.042%
11/12/2020AdvisorShares Investments LLC279,671$0.50M0.0%+47.3%0.342%
11/10/2020State Street Corp16,618,149$29.91M0.0%+445.6%20.337%
11/9/2020SG Americas Securities LLC1,228,106$2.21M0.0%+1,251.8%1.503%
11/9/2020The Manufacturers Life Insurance Company29,947$54K0.0%-22.9%0.037%
11/6/2020BlackRock Inc.5,903,239$10.63M0.0%-5.9%7.224%
11/6/2020Granite Point Capital Management L.P.298,624$0.54M0.0%-77.4%0.365%
11/5/2020New York State Common Retirement Fund61,300$0.11M0.0%+25.6%0.075%
11/5/2020California Public Employees Retirement System155,100$0.28M0.0%+15.7%0.190%
11/5/2020Wells Fargo & Company MN193,963$0.35M0.0%+11.9%0.237%
11/4/2020Raymond James & Associates41,598$75K0.0%-27.1%0.051%
11/3/2020Sigma Planning Corp32,000$58K0.0%N/A0.039%
11/2/2020D.A. Davidson & CO.44,924$81K0.0%-21.6%0.055%
10/30/2020BNP Paribas Arbitrage SA19,562$35K0.0%+174.4%0.024%
10/30/2020General American Investors Co. Inc.600,000$1.08M0.1%-15.8%0.734%
10/29/2020Cambridge Investment Research Advisors Inc.118,335$0.21M0.0%+79.6%0.145%
10/23/2020Pinnacle Associates Ltd.1,163,430$2.09M0.0%-3.4%1.424%
10/14/2020Aries Wealth Management33,400$60K0.0%+149.3%0.041%
9/15/2020Two Sigma Advisers LP52,100$0.44M0.0%N/A0.064%
9/4/2020Principal Financial Group Inc.26,206$0.22M0.0%N/A0.032%
8/25/2020Nuveen Asset Management LLC766,153$6.43M0.0%+203.5%0.938%
8/20/2020Charles Schwab Investment Management Inc.164,814$1.38M0.0%-2.1%0.202%
8/17/2020Engineers Gate Manager LP18,403$0.15M0.0%+36.3%0.023%
8/17/2020Great West Life Assurance Co. Can4,468$37K0.0%N/A0.005%
8/17/2020Jacobs Levy Equity Management Inc.117,608$0.99M0.0%+185.5%0.144%
8/14/2020Pinnacle Associates Ltd.1,204,407$10.11M0.2%-1.6%1.474%
8/14/2020Point72 Asset Management L.P.1,500,000$12.59M0.1%N/A1.836%
8/14/2020PDT Partners LLC122,457$1.03M0.1%N/A0.150%
8/14/2020Bank of America Corp DE38,940$0.33M0.0%+99.1%0.048%
8/14/2020Stifel Financial Corp22,528$0.19M0.0%-7.3%0.028%
8/14/2020Vanguard Group Inc.3,570,198$29.96M0.0%+0.4%4.369%
8/14/2020Advisor Group Holdings Inc.8,890$73K0.0%+52.9%0.011%
8/13/2020Tekla Capital Management LLC378,706$3.18M0.1%N/A0.463%
8/12/2020Bank of Montreal Can5,646$44K0.0%-48.5%0.007%
8/12/2020American International Group Inc.40,520$0.34M0.0%+4.0%0.050%
8/12/2020Goldman Sachs Group Inc.69,014$0.58M0.0%-4.4%0.084%
8/12/2020Bank of New York Mellon Corp270,618$2.27M0.0%+24.2%0.331%
8/12/2020Commonwealth Equity Services LLC12,105$0.10M0.0%N/A0.015%
8/12/2020California Public Employees Retirement System134,100$1.13M0.0%+8.4%0.164%
8/11/2020Aigen Investment Management LP26,294$0.22M0.0%N/A0.036%
8/10/2020D.A. Davidson & CO.57,300$0.48M0.0%+5.9%0.079%
8/10/2020Cambria Investment Management L.P.35,530$0.30M0.1%+6.3%0.049%
8/7/2020State Board of Administration of Florida Retirement System19,588$0.16M0.0%+27.6%0.027%
8/7/2020Virtu Financial LLC28,550$0.24M0.0%N/A0.039%
8/7/2020Rafferty Asset Management LLC31,893$0.27M0.0%N/A0.044%
8/7/2020Trexquant Investment LP63,201$0.53M0.0%N/A0.087%
8/6/2020Sawtooth Solutions LLC75,169$0.63M0.0%-8.9%0.104%
8/5/2020Principal Financial Group Inc.26,206$0.22M0.0%N/A0.036%
8/5/2020Virtus ETF Advisers LLC50,694$0.43M0.2%-28.9%0.070%
8/5/2020Russell Investments Group Ltd.310,930$2.61M0.0%+22.4%0.429%
8/5/2020Swiss National Bank145,600$1.22M0.0%N/A0.201%
8/5/2020AE Wealth Management LLC82,309$0.69M0.0%-8.0%0.114%
8/4/2020Arizona State Retirement System14,725$0.12M0.0%N/A0.020%
8/3/2020ProShare Advisors LLC20,590$0.17M0.0%+62.2%0.028%
7/31/2020UBS Group AG174,082$1.46M0.0%+327.2%0.240%
7/30/2020Hancock Whitney Corp16,962$0.14M0.0%N/A0.023%
7/28/2020Zurcher Kantonalbank Zurich Cantonalbank11,731$98K0.0%N/A0.016%
7/27/2020Cambridge Investment Research Advisors Inc.65,899$0.55M0.0%+37.1%0.091%
7/22/2020Davy Global Fund Management Ltd16,434$0.14M0.0%+49.5%0.023%
7/20/2020SG Americas Securities LLC90,848$0.76M0.0%+615.2%0.125%
7/17/2020Raymond James Financial Services Advisors Inc.271,585$2.28M0.0%-19.3%0.375%
7/14/2020AdvisorShares Investments LLC189,814$1.59M0.7%-39.9%0.262%
7/9/2020Aries Wealth Management13,400$0.11M0.1%-52.0%0.018%
6/19/2020State Street Corp1,156,624$6.06M0.0%+3.1%1.596%
Data available starting January 2016

See Full Table
Corbus Pharmaceuticals logo
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase III clinical trials for the treatment of systemic sclerosis and dermatomyositis, and in Phase IIb clinical trials to treat systemic lupus erythematosus and cystic fibrosis. The company is also developing CRB-4001, a peripherally-restricted CB1 inverse agonist, for nonalcoholic steatohepatitis and other fibrotic diseases. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.
Read More

Today's Range

Now: $1.84
$1.83
$1.94

50 Day Range

MA: $2.19
$1.80
$2.92

52 Week Range

Now: $1.84
$0.91
$9.78

Volume

2,105,354 shs

Average Volume

13,790,991 shs

Market Capitalization

$230.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.14

Who are the company insiders with the largest holdings of Corbus Pharmaceuticals?

Corbus Pharmaceuticals' top insider shareholders include:
  1. Sean F Moran (CFO)
  2. Barbara White (Insider)
  3. Yuval Cohen (CEO)
  4. Robert Paul Discordia (COO)
  5. Craig Stuart Millian (Insider)
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.